CTMX Earnings

Quarterly EPS
$0.07
Q3 2024
$0.22
Q4 2024
$0.27
Q1 2025
$0.00
Q2 2025
$-0.09
Q3 2025
$-0.17
Q4 2025
$-0.10
Q1 2026
$-0.09
Q2 2026
Latest Revenue1.4M
Latest Net Income-20666000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.091.4M-20666000-92.4%
Q1 2026-$0.1010.3M-18248000-79.9%-137.0%
Q4 2025-$0.17663.0K-26510000-98.3%-177.3%
Q3 2025-$0.096.0M-14229000-82.2%-228.6%
Q2 2025$0.0018.7M-154000-25.7%+100.0%
Q1 2025$0.2750.9M23.5M+22.8%+58.8%
Q4 2024$0.2238.1M18.9M+43.2%+2,100.0%
Q3 2024$0.0733.4M5.7M+26.7%+75.0%
Q2 2024-$0.0825.1M-6534000
Q1 2024$0.1741.5M13.8M
Q4 2023$0.0126.6M837.0K
Q3 2023$0.0426.4M3.0M
CytomX Therapeutics (CTMX) — Earnings